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www.cdatm.orgAbstractObjective: To investigate the prevalence of diabetic at-risk foot and its associated factors.
Methods: A total of 838 hospitalized patients with type 2 diabetes were screened for at-risk foot. Neural and vascular disorders
were evaluated by assessing vibration perception thresholds and ankle brachial indexes (ABIs). After excluding 12 patients with
abnormally high ABIs, remaining individuals with neural and/or vascular disorder were identified as at-risk patients and further
classified into three subtypes: isolated neural disorder, isolated vascular disorder and mixed disorder. Potential associated factors
were examined using Logistic regression models.
Results: In the final sample of 826 individuals, the prevalence of diabetic at-risk foot was 30.6%. Among all at-risk patients,
isolated neural disorders (69.6%) were more common than mixed (16.2%) or isolated vascular disorders (14.2%). Isolated neural
and vascular disorders shared specific risk factors, including age per 20-year increment (odds ratio [95% CI], 3.73 [2.59e5.37] and
4.01 [1.98e8.11]), diabetic duration10 years (1.69 [1.13e2.54] and 3.29 [1.49e7.24]) and systolic blood pressure140 mmHg
(1.96 [1.31e2.93] and 2.90 [1.38e6.10]) respectively. In addition, isolated neural disorders were associated with a heavy smoking
history (95%CI 2.69 [1.15e6.31]), increased high-sensitivity C-reactive protein levels (95%CI 1.30 [1.04e1.62]) and mild obesity
(95%CI 0.49 [0.20e1.24]). Isolated vascular disorders were linked with decreased high density lipoprotein (HDL) cholesterol
levels (95%CI 3.42 [1.31e8.96]) and increased triglycerides levels (95%CI 2.74 [1.26e5.97]).
Conclusions: Diabetic at-risk foot is epidemic among hospitalized patients with type 2 diabetes. Aging, long-term diabetes,
hypertension, smoking, inflammatory response and dyslipidemia may be associated with the prevalence of diabetic at-risk foot.
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Diabetic foot disease is one of the most common
and severe chronic complications of diabetes mellitus.
About 15e25% of patients with diabetes will develop a
foot ulcer during their lifetime.1 The most feared
consequence of a foot ulcer is lower-extremity ampu-
tation, which occurs about 23 times more often in
patients with diabetes than in the population without
diabetes.2 Diabetic foot lesions are difficult to be cured
but easily be prevented, which suggests the importance
of early identification of patients at risk.
Diabetic foot disease develops as a result of a
mixture of intrinsic conditions, such as neuropathy,
vascular disease and foot deformity, along with
extrinsic risks, such as unexpected trauma and infec-
tion, among which diabetic peripheral neuropathy
(DPN) and peripheral artery disease (PAD) are
believed to be the major initiating factors.2e4 PAD is
reported to be presented in 49% of foot ulcers in
Europe 5 and up to 90% of diabetic foot lesions are
related to neuropathy, alone or with ischemia, and the
incidence of neuro-ischemic problems has increased in
recent years.6 Therefore, screening tests focused on the
presence of DPN and PAD can predict the risk of
diabetic foot disease. Patients with diabetes and evi-
dence of peripheral neuropathy and/or ischemia should
be identified as individuals with at-risk foot. It is
estimated that early recognition and appropriate pro-
tection of at-risk foot can prevent 50% of diabetic ul-
cerations and amputations.3
In order to investigate the prevalence and clinical
characteristics of diabetic at-risk foot as well as to
explore potential associated factors, we conducted this
cross-sectional study on a population of hospitalized
adult patients diagnosed with type 2 diabetes in a
Chinese tertiary hospital from March 2013 to February
2014.
Materials and Methods
Study participants
The sample consisted of 899 consecutive hospital-
ized patients who underwent a diabetic foot screening
from March 1, 2013 to February 28, 2014 and were
diagnosed with diabetes at the Department of Endo-
crinology and Metabolic Disease of the First Affiliated
Hospital of Soochow University in China. Informedconsents were received from all participants. We
excluded patients who were; 1. not diagnosed with type
2 diabetes, 2. pregnant at the time of diabetic foot
screening, 3. aged <20 years at the time of diabetic
foot screening.
Screening criteria for diabetic at-risk foot
Every participant underwent a screening for dia-
betic at-risk foot on the first or second day after
admission. The screening process, as recommended by
the American Diabetes Association,7 was mainly
comprised of taking a history focused on neuropathic
and ischemic symptoms and a previous history of foot
ulcerations and amputations, a careful inspection to
detect foot deformities and inappropriate footwear, and
tests targeting the presence of DPN and PAD. The
vibration perception threshold (VPT) values of both
feet were measured using a sensimeter as a semi-
quantitative neurological assessment. A VPT over 25
volts has been associated with a high cumulative risk
of neuropathic ulcerations.8 Therefore, we defined
patients with a VPT >25 volts in at least one foot as
individuals with neural disorder. Plus, we tested ankle
brachial index (ABI) values of both sides using a
standard Doppler ultrasonic probe to evaluate the pe-
ripheral artery condition. The ABI value was obtained
by dividing the ankle systolic pressure by the higher of
the two brachial systolic pressures. An ABI 0.9 is
strongly linked with a 7-year risk of amputation in
people with diabetes.9 In this study, we considered
patients with an ABI 0.9 in either foot as individuals
with vascular disorder. Additionally, we excluded pa-
tients with an abnormally high ABI >1.310 on either
side: no patient presented with an ABI 0.9 in one
limb and an ABI >1.3 in the other. Patients with neural
and/or vascular disorders were identified as individuals
with at-risk foot. Otherwise, they were considered risk-
free subjects.
Data collection
Each patient's gender, age, duration of diabetes and
smoking history were collected on admission. Duration
of diabetes was categorized as either short (<10 years)
or long (10 years). The smoking history of each
patient was evaluated by the level of pack-years of
cigarette smoking (the total number of years smoked
times the average number of packs of cigarettes
Table 1
Characteristics of the study participants.
Characteristics Study participants
Gender (Male) 435 (52.7)
Age, years 61 (20)
Duration of diabetes 10 years 359 (43.5)
Smoking historya, pack-years
Never-smoker 685 (82.9)
Light-smoker (<20) 26 (3.1)
Median-smoker (20e39) 42 (5.1)
Heavy-smoker (40) 31 (3.8)
BMIa, kg/m2 23.8 (4.6)
Underweight (<18.5) 42 (5.1)
Normal-weight (18.5e23.9) 368 (44.6)
Overweight (24.0e27.9) 291 (35.2)
Mild obesity (28.0e29.9) 63 (7.6)
Severe obesity (30.0) 40 (4.8)
SBP 140 mmHg 293 (35.5)
HbA1ca <7.0% (53 mmol/mol) 107 (13.0)
Higher triglyceride levela (>1.7 mmol/l) 246 (29.8)
Lower HDL-C levela (<1.0 mmol/l for
male or <1.3 mmol/L for female)
482 (58.4)
Higher LDL-C levela (>2.6 mmol/l) 384 (46.5)
Higher hs-CRP levela (>3.0 mg/l) 303 (36.7)
Data are n (%) or median [interquartile range]. n ¼ 826. BMI: body
mass index; SBP: systolic blood pressure; HbA1c: haemoglobinA1c;
HDL-C: high density lipoprotein cholesterol; LDL-C: low-density
lipoprotein cholesterol; hs-CRP: high-sensitivity C-reactive protein;
a Numbers of subjects with missing values were 42 for smoking
history, 22 for BMI, 128 for HbA1c, 24 for triglyceride, 29 for HDL-
C, 21 for LDL-C and 30 for hs-CRP.
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never-smoker, a light-smoker (<20 pack-years), a
median-smoker (20e39 pack-years) or a heavy-smoker
(40 pack-years). Height and weight were measured
without shoes and heavy clothes. Body mass index
(BMI) was calculated as weight in kilograms divided
by the square of height in meters. Systolic blood
pressure (SBP) was measured on admission. The most
recent laboratory results of hemoglobin A1c (HbA1c),
triglycerides, low-density lipoprotein cholesterol
(LDL-C), high-density lipoprotein cholesterol (HDL-
C) and high-sensitivity C-reactive protein (hs-CRP)
were ascertained.
Statistical analyses
Individuals with at-risk foot were further classified
into three subtypes: isolated neural disorder (neural
disorder þ, vascular disorder ), isolated vascular dis-
order (neural disorder, vascular disorderþ) andmixed
disorder (neural disorder þ, vascular disorder þ). Cate-
gorical variables were presented as counts (percentages),
and continuous data that were not normally distributed
were presented as median [interquartile range]. The
prevalence rates of at-risk foot across age and duration of
diabetes were calculated. Stepwise multivariate Logistic
regression models (sle ¼ 0.20, sls ¼ 0.20) were used
to estimate the odds ratios (ORs) and 95% confidence
intervals (CIs) of isolated neural or isolated vascular
disorder in relation to sex, age, duration of diabetes,
smoking history, BMI, SBP, HbA1c, triglycerides, LDL-
C, HDL-C and hs-CRP. All analyses were performed
using the SAS software, version 8.1 (SAS Institute, Inc.,
Cary, NC, USA). Associations were considered statisti-
cally significant at the P < 0.05 level.
Results
By applying the initial exclusion criteria, we
excluded 35 patients with type 1 diabetes, 15 with
special types of diabetes, 5 with pregnancy and 6 with
type 2 diabetes but younger than 20 years old. Addi-
tionally, we removed 12 subjects with abnormally high
ABI (>1.3) to arrive at the final study sample of 826
patients (all Han Chinese). As displayed in Table 1,
there were 435 (52.7%) males and 391 (47.3%) females
in the study. The age ranged from 20 to 91 years old with
a median [interquartile range] of 61 [20] years old.
Almost half (43.5%) of patients had a duration of dia-
betes of 10 years or longer. Never-smokers and heavy-
smokers represented 82.9% and 3.8% of the sample,
respectively. According to the BMI measurement,normal-weight (44.6%) and overweight (35.2%) pa-
tients were more common than obese (12.4%) and un-
derweight (5.1%) patients among hospitalized patients
with type 2 diabetes. Moreover, 35.5% of patients had
elevated systolic blood pressure levels (140 mmHg)
and only 13.0% had recently reached HbA1c levels
<53 mmol/mol (7.0%). As for the lipid-metabolism
related parameters, more patients (58.4%) had lower
levels of HDL-C while fewer had higher levels of tri-
glycerides (29.8%) and LDL-C (46.5%). Plus, 36.7% of
patients had elevated hs-CRP levels (>3.0 mg/L).
We reviewed neuropathic and ischemic symptoms
reported in the patient history and found that only 11
patients, all of them had an ABI 0.9, complained
about experiencing typical claudication or rest pain,
and 139 (126 of them had a VPT >25 V) mentioned
symptoms possibly related to neural disorder (e.g.
numbness in the extremities, long-term itching without
skin lesions).
Prevalence of diabetic at-risk foot
Table 2 shows that the prevalence of at-risk foot was
30.6% among hospitalized adult patients with type 2
Table 2
Prevalence of diabetic at-risk foot across age and duration of diabetes.a
Foot screening Age 20e39 years Age 40e59 years Age 60e79 years Age 80 years Total (n ¼ 826)
Duration
<10 years
(n ¼ 72)
Duration
10 years
(n ¼ 7)
Duration
<10 years
(n ¼ 204)
Duration
10 years
(n ¼ 103)
Duration
<10 years
(n ¼ 176)
Duration
10 years
(n ¼ 224)
Duration
<10 years
(n ¼ 15)
Duration
10 years
(n ¼ 25)
Isolated neural disorder 1 (1.4) 0 (0) 18 (8.8) 20 (19.4) 44 (25.0) 76 (33.9) 7 (46.7) 10 (40.0) 176 (21.3)
Isolated vascular disorder 0 (0) 0 (0) 4 (2.0) 3 (2.9) 5 (2.8) 21 (9.4) 3 (20.0) 0 (0) 36 (4.4)
Mixed disorder 0 (0) 0 (0) 1 (0.5) 1 (1.0) 5 (2.8) 20 (8.9) 4 (26.7) 10 (40.0) 41 (5.0)
Total (at-risk foot) 1 (1.4) 0 (0) 23 (11.3) 24 (23.3) 54 (30.7) 117 (52.2) 14 (93.3) 20 (80.0) 253 (30.6)
Data are n (%) unless otherwise indicated.
a Both age per 20-year increment and duration of diabetes 10 years were significantly associated with isolated neural and vascular disorders.
Table 3
Associated factors of prevalent isolated neural disorder.a
Factors Isolated neural disorder (n ¼ 157)
n OR (95% CI) P
Age per 20-year increment 157 3.73 (2.59e5.37) <0.01
Smoking history, pack-years
Never-smoker 133 1.00 (ref.) e
Light-smoker (<20) 6 e e
Median-smoker (20e39) 6 e e
Heavy-smoker (40) 12 2.69 (1.15e6.31) 0.02
SBP 140 mmHg 78 1.96 (1.31e2.93) <0.01
Duration of diabetes
Shorter (<10 years) 64 1.00 (ref.) e
Longer (10 years) 93 1.69 (1.13e2.54) 0.01
Hs-CRP per 5 mg/L
increment
157 1.30 (1.04e1.62) 0.02
Male sex 86 1.39 (0.92e2.10) 0.11
BMI, kg/m2
Underweight (<18.5) 6 e e
Normal-weight (18.5e23.9) 83 1.00 (ref.) e
Overweight (24.0e27.9) 57 e e
Mild obesity (28.0e29.9) 6 0.49 (0.20e1.24) 0.13
Severe obesity (30.0) 5 e e
a ORs and 95% CIs were calculated using stepwise multivariate
logistic regression models (sle ¼ 0.20, sls ¼ 0.20). This model
included patients with isolated neural disorder (n ¼ 157, 19 obser-
vations deleted due to missing values) vs. risk-free subjects (n ¼ 511,
62 observations deleted due to missing values). All factors listed
entered into and stayed in the model during stepwise selection
procedure. Effects of the most recent laboratory results of HbA1c,
triglyceride, LDL-C and HDL-C did not meet the 0.20 significance
level for entry into the model. SBP: systolic blood pressure; hs-CRP:
high-sensitivity C-reactive protein; BMI: body mass index.
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the prevalence could reach up to 85.0% (34/40). On the
contrary, the prevalence rate was relatively low (1/79,
1.3%) in subjects younger than 40 years old. The
prevalence of at-risk foot increased with age dramati-
cally. Furthermore, in the age groups of 40e59 years
and 60e79 years, the prevalence in patients with a
longer duration of diabetes was approximately twice as
high as in patients with a shorter duration. Among all
patients with at-risk foot, isolated neural disorder,
isolated vascular disorder and mixed disorder accoun-
ted for 69.6% (176/253), 14.2% (36/253) and 16.2%
(41/253) respectively.
The prevalence rates of the three subtypes of dia-
betic at-risk foot were 21.3% for isolated neural dis-
order, 4.4% for isolated vascular disorder and 5.0% for
mixed disorder, respectively. All of them shared an
upward trend with age and duration of diabetes. Iso-
lated neural disorder was infrequent (1.3%, 1/79) in
patients aged 20e39 years but common (42.5%, 17/40)
in patients 80 years. Isolated vascular disorder and
mixed disorder were absent in 20e39 year-old subjects
but highly prevalent in those aged 80 years, 7.5% and
35.0%, respectively. Among at-risk patients, younger
individuals with a shorter duration of diabetes were
more likely to suffer from neural disorder, and in
comparison, older individuals with longer duration are
more likely to present with both neural and vascular
disorders.
Associated factors of diabetic at-risk foot
Potential associated factors of two subtypes of
diabetic at-risk foot, isolated neural disorder and iso-
lated vascular disorder, were examined separately
using stepwise multivariate logistic regression models.
In the model of isolated neural disorder (Table 3), age
per 20-year increment (OR [95% CI], 3.73
[2.59e5.37]) posed as the strongest risk factor,followed by heavy smoking history 40 pack-years
(2.69 [1.15e6.31]), systolic blood pressure
140 mmHg (1.96 [1.31e2.93]), duration of diabetes
10 years (1.69 [1.13e2.54]) and hs-CRP level per
5 mg/L increment (1.30 [1.04e1.62]). Although it
seemed that the effects of the male sex (1.39
[0.92e2.10]) and BMI values of 28.0e29.9 (0.49
[0.20e1.24]) were involved in the final model, the
relationships did not reach statistical significance. The
Table 4
Associated factors of prevalent isolated vascular disorder.a
Factors Isolated vascular disorder (n ¼ 36)
n OR (95% CI) P
Age per 20-year increment 36 4.01 (1.98e8.11) <0.01
Lower HDL-C (<1.0 mmol/L for male or <1.3 mmol/L for female) 30 3.42 (1.31e8.96) 0.01
Duration of diabetes
Shorter (<10 years) 12 1.00 (ref.) e
Longer (10 years) 24 3.29 (1.49e7.24) <0.01
SBP 140 mmHg 22 2.90 (1.38e6.10) <0.01
Higher triglyceride (>1.7 mmol/L) 17 2.74 (1.26e5.97) 0.01
Higher LDL-C (>2.6 mmol/L) 19 1.70 (0.79e3.66) 0.17
a ORs and 95% CIs were calculated using stepwise multivariate logistic regression models (sle ¼ 0.20 sls ¼ 0.20). This model included patients
with isolated vascular disorder (n¼ 36) vs. risk-free subjects (n¼ 548, 25 observations deleted due to missing values). All factors listed entered into
and stayed in the model during stepwise selection procedure. Effects of the male sex, smoking history, BMI, the most recent laboratory results of
HbA1c and hs-CRP did not meet the 0.20 significance level for entry into the model. SBP: systolic blood pressure.
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triglycerides, LDL-C and HDL-C were not signifi-
cantly associated with isolated neural disorder and
failed to enter into the model.
On the other hand, among all the risk factors in the
model of isolated vascular disorder (Table 4), age per
20-year increment had the highest OR [95% CI] of
4.01 [1.98e8.11], followed by the decreased HDL-C
level (<1.0mmol/L for males or <1.3mmol/L for fe-
males) at 3.42 [1.31e8.96], duration of diabetes 10
years at 3.29 [1.49e7.24], systolic blood pressure
140mmHg at 2.90 [1.38e6.10] and the increased
triglycerides level (>1.7mmol/L) at 2.74 [1.26e5.97].
The factor of an elevated LDL-C level (>2.6mmol/L)
with an OR [95% CI] of 1.70 [0.79e3.66] also entered
into and stayed in the model, but the association failed
to meet the significance level. The effects of the male
sex, smoking history, BMI and the most recent labo-
ratory results of HbA1c and hs-CRP failed to enter into
the model.
Discussion
The results from this cross-sectional study indicate
that diabetic at-risk foot is common (30.6%) among
hospitalized adult patients with type 2 diabetes. It is
highly prevalent (85.0%) in individuals 80 years old
and relatively rare (1.3%) in those <40 years old. The
prevalence steeply increases with advancing age and
duration of diabetes. Among patients with at-risk foot,
those with isolated neural disorder are the most com-
mon, followed by those with mixed disorder and iso-
lated vascular disorder. These findings provide an
estimate of the future burden of diabetic foot disease in
hospitalized patients with type 2 diabetes.Importantly, we excluded patients with abnormally
high ABI, which is related to calcification of the
arterial wall. Vascular calcification and occlusive le-
sions frequently coexist, and when calcification is
present, stenotic disease cannot be detected by the ABI
measurement.9 Plus, the coexistence of mild medial
arterial calcification in the lower extremities, which
causes abnormally high ABI,11 and clinically signifi-
cant PAD, which causes low ABI, may result in a
normal ABI.4 Moreover, the ABI test itself, whilst
highly sensitive in the general population, may be less
effective in individuals with diabetes, especially in
cases complicated by peripheral and autonomic neu-
ropathy.2 Therefore, it is likely that the prevalence of
isolated vascular and mixed disorders were under-
estimated in the study.
At present, numerous stratification systems using
different methods have been proposed to identify the
degree of risk for foot ulceration among patients with
diabetes. In spite of the differences with regard to the
development of prediction models, diagnostic accuracy
measures and validation and generalizability, five var-
iables were included in almost all the systems, namely:
diabetic neuropathy, peripheral vascular disease
(PVD), foot deformity, and previous foot ulcer and
amputation.12 In our study, we focused on the diabetic
neuropathy assessed by VPT >25V and PVD deter-
mined by ABI <0.9. According to the International
Working Group on the Diabetic Foot (IWGDF)
guidelines,1,13 patients with isolated neural disorder in
the present investigation might be assigned to risk
stratification category 1 in need of foot examination
every six months, while patients with mixed disorder
are risk stratification category 2 which requires foot
examination every three months.
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may contribute to better protective strategies. Previous
investigations have shown that the incidence of neu-
ropathy was related to smoking, hypertension and
higher levels of triglycerides and BMI in patients with
type 1 diabetes.14 And Herder et al15 found the asso-
ciation between subclinical inflammation and diabetic
polyneuropathy in type 2 diabetes. Joosten et al16 re-
ported that hypertension, smoking, diabetes mellitus
and hypercholesterolemia accounted for most of the
risk associated with the development of clinically
significant PAD in males. In the present study, we
discovered that among hospitalized adult patients with
type 2 diabetes, prevalent isolated neural and vascular
disorders might share the role of main risk factors of
aging, long-term diabetes and hypertension. We also
found that the prevalence rates of both conditions were
strongly linked with the duration of diabetes rather
than the most recent HbA1c level, suggesting that
diabetic neural and vascular diseases are chronic dis-
orders that cannot be predicted by a single recent
HbA1c result. Various studies have shown that glyce-
mic control is the critical factor in the development of
diabetes and its complications. Therefore, more studies
are needed to investigate whether other indexes, such
as HbA1c variability or continuous glucose variability,
are suitable to represent glycemic control with respect
to such long-term complications.
In addition, cumulative smoking exposure and
higher hs-CRP level have a significant impact on the
prevalence of isolated neural disorder, indicating a vital
role of an inflammatory response in prevalent DPN. A
heavy smoking history, in particular, stands out to be
the second greatest risk factor for developing periph-
eral neuropathy among hospitalized patients with type
2 diabetes. Another interesting finding is the negative
relationship between mild obesity and isolated neural
disorder, although it did not reach statistical signifi-
cance. This kind of obesity paradox was also found in
foot ulceration risk17 and lower-extremity amputation
risk18 but lacked a valid explanation.
On the other hand, dyslipidemia, which is charac-
terized by a decreased HDL-C level but not an
increased LDL-C level, appears to play a crucial role in
the prevalence of isolated vascular disorder. The PAD
is not a specific complication of diabetes but one of the
most common manifestations of atherosclerosis in the
lower extremities. It is well-established that smoking
has a major influence on the initiation and progression
of atherosclerosis. Additionally, Conen et al19
confirmed that smoking was a potent risk factor for
the occurrence of symptomatic PAD among womenand smoking cessation was associated with a substan-
tial reduction in the risk. We assume the reason why
the effect of the smoking history failed to meet asso-
ciative significance in this study would be the small
proportion of smokers and small number of patients
with isolated vascular disorder, which resulted in
limited statistical power.
The strengths of this study are the relatively large
sample population and the screening criteria of dia-
betic at-risk foot based on semi-quantitative or quan-
titative tests. However, several limitations do exist.
First, neural and vascular disorders of diabetic foot are
both integrated conditions with multiple assessments.
A single examination might be inaccurate. However,
the tests we used have been proven to possess rela-
tively high sensitivity and specificity as well as pre-
dictive power,8,9 and we examined both feet of every
participant to reduce the rate of misdiagnosis. Second,
information on medication and comorbid diseases were
not included. Third, the temporality of the presented
associations is unclear due to the cross-sectional design
of this study.
In summary, the prevalence of diabetic at-risk foot
is about 30% among hospitalized adult patients diag-
nosed with type 2 diabetes. However, it is estimated20
that only 10e20% of the patients with PAD present a
typical claudication and 30e40% of the patients with
neuropathy are asymptomatic in China. The discrep-
ancy between the high prevalence and the low rate of
awareness of at-risk foot puts patients with diabetes in
a dangerous zone for progression to foot ulceration and
even amputation. Therefore, frequent foot screening
and appropriate control of risk factors should be taken
to identify at-risk patients and to reduce the occurrence
and potential consequences of diabetic foot disease.
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